₹0.54
▼ -0.01 -1.82%
17 Jul 2026
BSE Listed
GSM 0Shree Ganesh Bio-Tech (Ind (539470)
Volume: 4,26,363Avg Vol 1W: 5,12,339Avg Vol 1M: 5,55,33852W Range:₹0.52₹0.83
Key Ratios
Checked just nowMarket Cap₹22 Cr
Current Price₹0.54
Previous Close₹0.55
High / Low (52w)₹0.83 / ₹0.52
Volume4,26,363
Avg Vol (1W)5,12,339
Avg Vol (1M)5,55,338
Stock P/E54
Book Value₹1.6
Dividend Yield0%
ROE59.34%
ROA79.94%
Revenue (TTM)—
Revenue Growth—
Profit Margin10.26%
Total Debt—
Shares Outstanding40 Cr
Face Value—
EPS (TTM)₹0.01
P/B0.34
Debt / Equity0
50 DMA₹0.58
200 DMA₹0.64
Day change-1.82%
SurveillanceGSM 0 (as of 2026-07-17)
Price Chart
₹0.54▼ 33.33% · 1Y
2025-07-172026-07-17
20-day avg volume: 5.7L shares
Pros
- Healthy return on equity of 59.3%.
- Company is almost debt-free.
- Revenue grew 14% YoY.
- Stock trades below its book value.
Cons
- Stock trades at a high P/E of 54.
Quarterly Results
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹4 Cr | ₹2 Cr | ₹14 Cr | ₹3 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹2 Cr |
| EBITDA | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹-1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Net Profit | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹-1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹8 Cr | ₹6 Cr | ₹2 Cr | ₹17 Cr | ₹73 Cr | ₹63 Cr | ₹21 Cr | ₹24 Cr |
| EBITDA | ₹4 Cr | ₹2 Cr | ₹0 Cr | ₹1 Cr | ₹3 Cr | ₹3 Cr | ₹1 Cr | ₹0 Cr |
| Net Profit | ₹4 Cr | ₹2 Cr | ₹0 Cr | ₹0 Cr | ₹3 Cr | ₹2 Cr | ₹1 Cr | ₹0 Cr |
| EPS | 19.12 | 0.9 | 0.12 | 0.02 | 0.13 | 0.05 | 0.02 | 0.01 |
Balance Sheet
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹26 Cr | ₹64 Cr | ₹65 Cr | ₹75 Cr | ₹94 Cr | ₹80 Cr | ₹74 Cr | ₹63 Cr |
| Total Liabilities | ₹3 Cr | ₹7 Cr | ₹7 Cr | ₹17 Cr | ₹33 Cr | ₹17 Cr | ₹11 Cr | ₹0 Cr |
| Equity | ₹23 Cr | ₹57 Cr | ₹57 Cr | ₹58 Cr | ₹60 Cr | ₹62 Cr | ₹63 Cr | ₹63 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Operating | ₹2 Cr | ₹5 Cr | ₹11 Cr | ₹10 Cr | ₹-10 Cr |
| Investing | ₹-2 Cr | ₹-3 Cr | ₹-10 Cr | ₹-10 Cr | ₹10 Cr |
| Financing | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Free Cash Flow | ₹2 Cr | ₹5 Cr | ₹11 Cr | ₹10 Cr | ₹-10 Cr |
Shareholding
Promoter 0% Institutions 1.42% Public 98.58%
Efficiency & Working Capital
ROCE0.8%
Interest Coverage0
Dividend Payout—
Debtor Days0 d
Inventory Days46 d
Payable Days0 d
Cash Conversion Cycle46 d
Working Capital Days46 d
Shareholding Details
As of 2026-03-31
Promoter0%
FII1.4%
DII0%
Institutions1.4%
Public98.6%
Promoter Pledge—
No. of Shareholders1,83,658
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| FIIs | 2.4% | 2.2% | 2.2% | 1.4% | 1.4% | 1.4% | 1.4% | 1.4% | 1.4% | 1.4% | 1.4% | 1.4% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 97.6% | 97.8% | 97.8% | 98.6% | 98.6% | 98.6% | 98.6% | 98.6% | 98.6% | 98.6% | 98.6% | 98.6% |
| Promoter Pledge | — | — | — | — | — | — | — | — | — | — | — | — |
| No. of Shareholders | 71,811 | 78,096 | 1,39,880 | 1,76,722 | 1,81,198 | 1,85,335 | 1,92,040 | 1,95,435 | 1,92,235 | 1,89,375 | 1,86,148 | 1,83,658 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| New Era Fund Limited | Public Shareholding | 1.4% | 56,64,940 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| New Era Fund Limited | 0 | 0% | 2026-03-31 |
| New Era Fund Limited | 0 | 0% | 2025-12-31 |
| New Era Fund Limited | 0 | 0% | 2025-09-30 |
| New Era Fund Limited | 0 | 0% | 2025-06-30 |
| New Era Fund Limited | 0 | 0% | 2025-03-31 |
| New Era Fund Limited | 0 | 0% | 2024-12-31 |
| New Era Fund Limited | 0 | 0% | 2024-09-30 |
| New Era Fund Limited | 0 | 0% | 2024-06-30 |
| New Era Fund Limited | 0 | 0% | 2024-03-31 |
| New Era Fund Limited | 0 | 0% | 2023-12-31 |
| Ashok Kumar | 0 | 0% | 2023-12-31 |
| New Era Fund Limited | 0 | 0% | 2023-09-30 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Aman Patel | Chairman / Executive Director / WTD | 2025 |
| Kishan Nityanand Naidu | Executive Director & CFO | 2025 |
| SOMBIR SINGH | Independent Non Exe. Director | 2025 |
| Amrutaben Solanki | Independent Non Exe. Director | 2025 |
| Nimeshkumar Parmar | Independent Non Exe. Director | 2025 |
| Harshadkumar Rathod | Independent Non Exe. Director | 2025 |
| Namita Acharya | Company Sec. & Compli. Officer | 2025 |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹1 | 40 | 40 | 40 |
Substantial Acquisitions (SAST)
5 disclosure(s)
Market25/09/2023 - 17/10/2023 · 1,99,00,000
Market12/09/2023 - 16/10/2023 · 2,61,00,000
Off Market11/09/2023 - 13/09/2023 · 3,23,00,000
Market08/09/2023 · 1,95,00,000
Market06/09/2023 · 1,95,50,000
Company Information
🌐 www.shreeganeshbiotech.com ↗
📍 6 Flr Premises-602 Mahavir Apt, 2 Aushutosh Mukherjee Road, Kolkata, West Bengal, 700020
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search